Prognostic factors and their importance in relapsed and refractory AML: Comments on "Additional impact of mutational genotype on prognostic determination in resistant and relapsed acute myeloid leukaemia" by Linch et al.

Chandra Sekaran, Usha; Grove, Carolyn S

Chandra Sekaran, Usha; Grove, Carolyn S.

Afiliação

Chandra Sekaran U; Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia; Department of Haematology, PathWest Laboratory Medicine, Perth, Australia.
Grove CS; Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia; Department of Haematology, PathWest Laboratory Medicine, Perth, Australia; School of Biomedical Sciences, University of Western Australia, Perth, Australia. Electronic address: carolyn.grove@health.wa.gov.au.

Leuk Res ; 105: 106572, 2021 06.

Article em En | MEDLINE | ID: mdl-33836481

Assuntos

Leucemia Mieloide Aguda; Recidiva Local de Neoplasia; Citarabina; Genótipo; Humanos; Leucemia Mieloide Aguda/tratamento farmacológico; Leucemia Mieloide Aguda/genética; Recidiva Local de Neoplasia/genética; Prognóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google